91 related articles for article (PubMed ID: 36795195)
1. Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study.
Nappo F; Fornaro L; Pompella L; Catanese S; Lavacchi D; Spallanzani A; Cappetta A; Puzzoni M; Murgioni S; Barsotti G; Tirino G; Pellino A; Vivaldi C; Strippoli A; Aprile G; Di Donato S; Mazza E; Prisciandaro M; Antonuzzo L; Zagonel V; Cascinu S; De Vita F; Lonardi S
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6601-6611. PubMed ID: 36795195
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials.
Raimondi A; Kim YW; Kang WK; Langley RE; Choi YY; Kim KM; Nankivell MG; Randon G; Kook MC; An JY; Grabsch HI; Prisciandaro M; Nichetti F; Noh SH; Sohn TS; Kim S; Wotherspoon A; Morano F; Cunningham D; Lee J; Cheong JH; Smyth EC; Pietrantonio F
Eur J Cancer; 2024 May; 203():114043. PubMed ID: 38598921
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Mismatch Repair Status on Prognosis of Patients With Gastric Cancer: A Multicenter Analysis.
Guan WL; Ma Y; Cui YH; Liu TS; Zhang YQ; Zhou ZW; Xu JY; Yang LQ; Li JY; Sun YT; Xu RH; Wang FH; Qiu MZ
Front Oncol; 2021; 11():712760. PubMed ID: 34900669
[TBL] [Abstract][Full Text] [Related]
4. Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action.
Fornaro L; Lonardi S; Catanese S; Nappo F; Pietrantonio F; Pellino A; Angerilli V; Signorini F; Salani F; Murgioni S; Neculaescu IA; Bruno R; Vivaldi C; Ricagno G; Masi G; Bergamo F; Ugolini C; Fassan M
Gastric Cancer; 2023 Nov; 26(6):958-968. PubMed ID: 37382783
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients.
Hiltner T; Kohlruss M; Herz AL; Lorenzen S; Novotny A; Hapfelmeier A; Jesinghaus M; Slotta-Huspenina J; Sisic L; Gaida MM; Weichert W; Ott K; Keller G
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7651-7662. PubMed ID: 37000259
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy.
Wu H; Ma W; Jiang C; Li N; Xu X; Ding Y; Jiang H
Ann Surg Oncol; 2023 Dec; 30(13):8572-8587. PubMed ID: 37667098
[TBL] [Abstract][Full Text] [Related]
7. Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.
Strickland MR; Lander EM; Gibson MK; Ilson DH; Ajani JA; Klempner SJ
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38503041
[TBL] [Abstract][Full Text] [Related]
8. Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study.
Oaknin A; Pothuri B; Gilbert L; Sabatier R; Brown J; Ghamande S; Mathews C; O'Malley DM; Kristeleit R; Boni V; Gravina A; Banerjee S; Miller R; Pikiel J; Mirza MR; Dewal N; Antony G; Dong Y; Zografos E; Veneris J; Tinker AV
Clin Cancer Res; 2023 Nov; 29(22):4564-4574. PubMed ID: 37363992
[TBL] [Abstract][Full Text] [Related]
9. Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy: A Retrospective Cohort Study.
Vos EL; Maron SB; Krell RW; Nakauchi M; Fiasconaro M; Capanu M; Walch HS; Chatila WK; Schultz N; Ilson DH; Janjigian YY; Ku GY; Yoon SS; Coit DG; Vanderbilt CM; Tang LH; Strong VE
Ann Surg; 2023 May; 277(5):798-805. PubMed ID: 35766391
[TBL] [Abstract][Full Text] [Related]
10. Low microsatellite instability: A distinct instability type in gastric cancer?
Kohlruss M; Chakraborty S; Hapfelmeier A; Jesinghaus M; Slotta-Huspenina J; Novotny A; Sisic L; Gaida MM; Ott K; Weichert W; Pfarr N; Keller G
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17727-17737. PubMed ID: 37819581
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of microsatellite instability and immune escape mechanism in patients with gastric solid-type poorly differentiated adenocarcinoma.
Umekita S; Kiyozawa D; Kohashi K; Kawatoko S; Sasaki T; Ihara E; Oki E; Nakamura M; Ogawa Y; Oda Y
Gastric Cancer; 2024 May; 27(3):484-494. PubMed ID: 38441781
[TBL] [Abstract][Full Text] [Related]
12. Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain.
Garcia-Carbonero R; González Astorga B; Vidal Tocino R; Contreras Toledo D; Pericay C; Fernández Montes A; Falcó E; González Cordero M; Reina Zoilo JJ; Alonso V; Rodríguez Salas N; Gil-Raga M; Santos C; Páez D; Anton-Pascual B; Aguilar F; Morales P
Clin Transl Oncol; 2024 Apr; 26(4):864-871. PubMed ID: 37651021
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant and/or adjuvant chemotherapy for gastric cancer patients with microsatellite instability or deficient mismatch repair: a systematic review and meta-analysis study protocol.
Liu B; Yin X; Cai Z; Shen C; Jiang T; Han Y; Yin Y; Zhang B
BMJ Open; 2024 Apr; 14(4):e084496. PubMed ID: 38670615
[TBL] [Abstract][Full Text] [Related]
14. Perioperative Chemotherapy for Gastro-Esophageal or Gastric Cancer: Anthracyclin Triplets versus FLOT.
Geerts JFM; van der Zijden CJ; van der Sluis PC; Spaander MCW; Nieuwenhuijzen GAP; Rosman C; van Laarhoven HWM; Verhoeven RHA; Wijnhoven BPL; Lagarde SM; Mostert B
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610969
[No Abstract] [Full Text] [Related]
15. Detecting Microsatellite Instability in Endometrial, Colon, and Stomach Cancers Using Targeted NGS.
Boyarskikh U; Kechin A; Khrapov E; Fedyanin M; Raskin G; Mukhina M; Kravtsova E; Tsukanov A; Achkasov S; Filipenko M
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894432
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction.
Gebauer F; Plum PS; Damanakis A; Chon SH; Popp F; Zander T; Quaas A; Fuchs H; Schmidt T; Schröder W; Bruns CJ
Ann Surg Oncol; 2023 Nov; 30(12):7422-7433. PubMed ID: 37210683
[TBL] [Abstract][Full Text] [Related]
17. Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer.
Furukawa K; Hatakeyama K; Terashima M; Urakami K; Koseki Y; Fujiya K; Tanizawa Y; Bando E; Yamaguchi K
Gastric Cancer; 2024 May; ():. PubMed ID: 38744779
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Pathological Response Rate and Complications of FOLFOX versus FLOT Regimen in Perioperative Chemotherapy for Resectable Gastric Cancer: A Prospective Study.
Arefpour AM; Hosseini S; Basi A; Novin K; Foroughi A; Garousi M
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2791-2797. PubMed ID: 37642066
[TBL] [Abstract][Full Text] [Related]
19. Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers.
Shahnam A; Nindra U; McNamee N; Yoon R; Asghari R; Ng W; Karikios D; Wong M
Gastrointest Tumors; 2023; 10(1):19-28. PubMed ID: 37901653
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Nutritional Index in patients with microsatellite instability-high metastatic gastric or gastroesophageal cancers receiving immune checkpoint inhibitors.
Ghelardi F; Fucà G; Cavalli C; Shitara K; Cohen R; Ambrosini M; Maron SB; Cerantola R; Nasca V; Liberti GD; Zambelli L; Palazzo M; Salati M; Aoki Y; Kawazoe A; Cowzer D; Lonardi S; André T; Randon G; Pietrantonio F
Dig Liver Dis; 2024 May; ():. PubMed ID: 38772790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
